RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.86B
AUM Growth
-$456M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1 +$64M
2 +$36.2M
3 +$32.7M
4
MYOV
Myovant Sciences Ltd.
MYOV
+$27.2M
5
XFOR icon
X4 Pharmaceuticals
XFOR
+$12.9M

Top Sells

1 +$106M
2 +$70.5M
3 +$61.1M
4
AXSM icon
Axsome Therapeutics
AXSM
+$50.3M
5
KALV icon
KalVista Pharmaceuticals
KALV
+$41.2M

Sector Composition

1 Healthcare 97.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$476M 25.54%
4,132,442
2
$203M 10.89%
7,775,207
3
$178M 9.55%
3,722,504
+1,340,336
4
$137M 7.35%
4,858,260
5
$131M 7.05%
9,724,598
6
$113M 6.05%
2,162,671
7
$71.5M 3.84%
510,833
8
$59.5M 3.19%
6,880,323
-1,318,014
9
$59.2M 3.18%
6,545,642
+3,001,415
10
$46.9M 2.52%
1,875,209
11
$41.5M 2.23%
1,884,782
12
$38.7M 2.08%
2,456,669
13
$37.1M 1.99%
1,688,412
-450,000
14
$36.2M 1.94%
+2,743,625
15
$34.5M 1.85%
1,340,828
-1,952,961
16
$32.7M 1.75%
+1,119,963
17
$28.9M 1.55%
90,840
18
$28.3M 1.52%
495,608
19
$24.4M 1.31%
61,412
20
$21.3M 1.14%
179,296
21
$19M 1.02%
1,000,000
22
$14.8M 0.8%
483,990
+120,939
23
$12.9M 0.69%
+28,713
24
$10.4M 0.56%
3,247,005
+389,862
25
$7.34M 0.39%
+200,000